Termine
Unsere Präsentationen:
-
B. M. Bader, C. Fahrun, M. Zwar, K. Jügelt, O. H.-U. Schroeder, A. Gramowski-Voss;
A novel developmental in vitro assay: Functional characterization and quantification of GABAA receptor subunits during cortical development
Sonnabend, 12. November 2011, 13:00 - 17:00 Uhr (16:00 - 17:00 Uhr)
41.08 / E19 - GABA-A Receptor Physiology
-
B. M. Bader, S. Kniest, K. Jügelt, M. Kriebel, H. Volkmer, O. H.-U. Schroeder, A. Gramowski-Voss;
Enhanced predictive drug development: Functional screening of the GABAAR alpha1 subunit using receptor-specific RNA interference, MEA recordings and substance classification
Sonnabend, 12. November 2011, 13:00 - 17:00 (13:00 - 14:00 Uhr)
41.13 / E24 - GABA-A Receptor Physiology
-
O. H.-U. Schroeder, K. Jügelt, B. Bader, A. Gramowski-Voss;
Comparison of orthosteric and allosteric GABA-B receptor modulators by their electrophysiological activity patterns on in vitro microcircuits from frontal cortex tissue
Sonntag, 13. November 2011, 13:00 - 17:00 Uhr (14:00 - 15:00 Uhr)
233.06 / C8 - GABA-B Receptors
-
L. Schultz, B. M. Bader, K. Jügelt, A. Gramowski-Voss, O. H.-U. Schroeder;
Profiling the complex mode of action of clozapine as a lead compound in antipsychotics drug development - Functional screening with primary neuronal networks on MEA neurochips
Dienstag, 15. November 2011, 8:00 - 12:00 Uhr (9:00 - 10:00 Uhr)
567.22 / Y31 - Animal Models of Psychotic Diagnoses: GABA and Amines
-
K. Jügelt, O. H.-U. Schroeder, A. Gramowski-Voss;
Highly sensitive TTX assay: Cortical network activity responses 100-fold more sensitive to tetrodotoxin than associated action potential wave forms
Mittwoch, 16. November 2011, 08:00 Uhr - 12:00 Uhr (8:00 - 9:00 Uhr)
760.17 / B56 - Sodium Channels: Physiology, Pharmacology, and Gating
|
|
